The Center for Genetic Engineering and Biotechnology is pleased to invite researchers, authorities, specialists, health program managers, students, professionals, biopharmaceutical producers and businessmen who work to preserve the health of people with diabetes, to join us in the VI edition of the International Congress “Controlling diabetes and its most severe complications”, from August 31st to September 4th, 2022, at the Plaza América Convention Center, in Varadero, Matanzas, Cuba.
This important international congress, sponsored by prestigious organizations, will feature Cuban and foreign speakers and delegates from more than 40 countries, who will exchange their experiences and expand their knowledge regarding the most advanced in the control of diabetes mellitus under a COVID-19 epidemiological scenario, the molecular mechanisms of healing, therapies for diabetic foot ulcers, the implementation of health programs aimed at the comprehensive care of people with diabetes, and orthopedic treatments of foot deformities in people with diabetes mellitus.
As in previous editions, world experts and leaders in diabetes, endocrinology, molecular biology and vascular surgery will show their experiences in controlling and minimizing the negative impact caused by diabetes mellitus. Plenary lectures, oral presentations and electronic posters will be presented in English, with simultaneous translation facilities.
During the congress, several collateral activities will be organized to further enhance their participation.
Fraternal greetings,
Organizing Committee
Required digital form that allows entry into the national territory of Cuba. You must complete it before your arrival in the country.
D’VIAJEROS it is a process that facilitates and improves the experience of travelers in their transit through the Republic of Cuba, it can provide advanced information to speed up procedures at the different points of entry. It is mandatory for each passenger to truthfully complete the information provided to the Directorate of Identification, Immigration and Foreigners, the Custom General of the Republic and the Ministry of Public Health.
To submit the abstract
Fill out the registration form in English or Spanish; preferably in English.
If you cannot fill out the form or attach the abstract, you can send it to hptcongress@cigb.edu.cu with the requested information. Use as subject of the message: Abstract submission-Congress 2022.
You must adapt it to the PowerPoint template provided on the website, and you will plan 15 minutes of presentation and 5 minutes to answer possible questions (10 to 15 sheets maximum).
You must adapt it to the template in digital format provided on the website.
On line registration through our website (http://hptcongress.cubagrouplanner.com) is a simple process of only 5 steps, before you receive final confirmation:
Inscription | |
Participants | Fee (EUR) |
Private sector | 800 |
Delegate | 600 |
Student | 150 |
Companion | 150 |
Lodging (USD) | |
Double room | 135.00 USD x pax for each night |
Simple room | 189.00 USD x pax for each night |
All registrations require prepayment.
Event registration rates are subject to changes except when reservations have been confirmed. All rates are quoted in Euros. If any change involves an increase in price/rate, payment will be required at the time of change and the change and it will not be effective until payment is received and confirmed.
The total charge includes all services described by registration category, as well as fees for access and booking. Any incidental charges such as airport taxes, parking, phone calls, tips and room service will be handled directly between you and the supplier or property.
Cancellations or changes must be received in writing to $EVENTMAIL$
Once you have paid for your registration, the following cancellation policy applies:
Devolution it will be to the same credit card that you made a payment, except 20.00 % for administration fees.
• Diabetes prevention
• Diabetes as metabolic syndrome
• Association between obesity and diabetes
• Diabetes type 1 and 2, main scientic results in their detection, metabolic control and treatments
• Gestational diabetes
• Management of diabetic complications: retinopathy, nephropathy and neuropathy
• Diabetes control with insulin
• Control and monitoring of atherogenic dyslipidemia: hypertriglyceridemia, low density lipoprotein (HDL) and low density lipoprotein (LDL)
• Arterial hypertension
• Hyperglycemia
• Centripetal obesity
• Alterations in the function of platelets
• Association of oral hygiene and caries in the diabetic patient with the risk of cardiovascular involvement
• Treatments aimed at the prevention and management of cardiovascular complications
• New therapies in clinical trials
• Diabetes and COVID-19
• Health programs for the integral care to diabetic patients
• Active screening in communities for the early detection of diabetic foot ulcers
• Association of primary, secondary and tertiary care in comprehensive care for diabetic patients
• Implementing community programs for the early detection and care of gestational diabetes
• New developments and clinical researchs for the control of diabetes mellitus
• Pharmacovigilance and post-marketing studies of new therapies for diabetic foot ulcers
• Biosafety of using human recombinant epidermal growth factor to treat diabetic foot ulcers
Biopharmaceutical products